Genoray Co., Ltd. (KOSDAQ:122310)
South Korea · Delayed Price · Currency is KRW 3,330.00
+20.00 (0.60%)
At close: Oct 2, 2026
Genoray Market Cap
Genoray has a market cap or net worth of 42.4 billion as of October 2, 2026. Its market cap has decreased by -32.18% in one year.
Market Cap
42.40B
Enterprise Value
58.06B
Revenue
107.88B
Ranking
n/a
PE Ratio
15.94
Stock Price
3,330.00
ChartMarket Cap Chart
Since May 28, 2018, Genoray's market cap has decreased from 150.47B to 42.40B, a decrease of -71.82%. That is a compound annual growth rate of -14.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 42.40B | -16.10% |
| Dec 30, 2025 | 50.53B | -27.84% |
| Dec 30, 2024 | 70.03B | -26.75% |
| Dec 28, 2023 | 95.60B | -11.63% |
| Dec 29, 2022 | 108.18B | -23.55% |
| Dec 30, 2021 | 141.51B | 1.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| May 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hironic | 78.43B |
| Remed | 77.81B |
| SELVAS Healthcare | 71.49B |
| DRGEM | 56.33B |
| Dynamic solution | 55.99B |
| QuantaMatrix | 46.41B |
| JPI Healthcare | 45.28B |
| Genesystem | 34.72B |